Results 231 to 240 of about 73,182 (298)

Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report. [PDF]

Front Immunol
Liu Z, Wang F, Zhang Y, Lu J, Yang Y.
europepmc   +1 more source

Hepatitis B Virus Variants and Cytokine Patterns in Acute Liver Failure and Transplant‐Free Survival

Liver International, Volume 45, Issue 7, July 2025.
ABSTRACT Background & Aims Only 25% of hepatitis B‐related acute liver failure (HBV‐ALF) patients survive without liver transplantation (transplant‐free survival, TFS). There is limited study of immunological and virological profiles in these patients.
Nishi H. Patel, Annie Y. Chen, Carla Osiowy, Valerie Durkalski Mauldin, William M. Lee, Carla S. Coffin, Constantine J. Karvellas, the US Acute Liver Failure Study Group, W. M. Lee, Anne M. Larson, Iris Liou, Oren Fix, Michael Schilsky, Timothy McCashland, J. Eileen Hay, Natalie Murray, A. Obaid S. Shaikh, Andres Blei, Daniel Ganger, Atif Zaman, Steven H. B. Han, Robert Fontana, Brendan McGuire, Raymond T. Chung, Alastair Smith, Robert Brown, Jeffrey Crippin, Edwin Harrison, Adrian Reuben, Santiago Munoz, Rajender Reddy, R. Todd Stravitz, Lorenzo Rossaro, Raj Satyanarayana, Tarek Hassanein, Constantine J. Karvellas, Jodi Olson, Ram Subramanian, James Hanje, Ezmina Lalani, Carla Pezzia, Nahid Attar, Linda S. Hynan, Valerie Durkalski, Wenle Zhao, Jaime Speiser, Catherine Dillon, Holly Battenhouse, Michelle Gottfried   +48 more
wiley   +1 more source

Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential

Obesity Reviews, Volume 26, Issue 7, July 2025.
Summary With the evolving landscape of diseases, heart failure with preserved ejection fraction (HFpEF) now encompasses more than half of all heart failure patients. This condition is clinically diverse, involving multiple organ systems and often occurring alongside the aging process.
Zhongwen Qi, Dan Wu, Zhipeng Yan, Qing Wang, Yiming Li, Junnan Zhao, Fengqin Xu   +6 more
wiley   +1 more source

Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma

International Journal of Cancer, Volume 156, Issue 12, Page 2416-2428, 15 June 2025.
What's new? In hepatocellular carcinoma, expanded myeloid‐derived suppressor cells (MDSC) relate to aggressiveness and poor prognosis. A global analysis of the different MDSC subsets in hepatocellular carcinoma is, however, missing. In this study, all three subsets of M‐MDSC, PMN‐MDSC, and eMDSC, together with arginase 1 activity, were significantly ...
Marta Chivite‐Lacaba, Iago Justo, Alberto Utrero‐Rico, Oscar Caso, Cecilia González‐Cuadrado, Manuel J. Del Rey, Rocio Laguna‐Goya, Javier Arroyo‐Ródenas, Ángel Alfocea‐Molina, Carlota C. Ruigómez‐Martín, Manuel Serrano, Lorena Pascual‐Palacios, María Esther Mancebo, Estela Paz‐Artal   +13 more
wiley   +1 more source

Expression of human granulocyte‐macrophage colony‐stimulating factor gene in insect cells by a baculovirus vector

, 1990
Chuang-Jiun Chiou, Ming‐Chi Wu
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Granulocyte-Macrophage Colony-Stimulating Factor

Biotherapy, 1990
The control of blood cell production is modulated directly or indirectly by more than ten different hematopoietic growth factors (Metcalf 1984). Many names have been assigned to each of the hematopoietic growth factors: although a specific set of names is used throughout this article, the alternative names can be found in other reviews (Nicola and ...
S. Devereux, D. C. Linch
  +8 more sources

Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

New England Journal of Medicine, 1992
FOUR colony-stimulating factors influence the survival, proliferation, differentiation, and functional activation of myeloid hematopoietic cells: macrophage colony-stimulating factor (M-CSF), granulocyte colony-stimulating factor (G-CSF), granulocytemacrophage colony-stimulating factor (GM-CSF), and interleukin-3 (formerly known as multi-colony ...
Alastair J.J. Wood, Graham J. Lieschke, Antony W. Burgess   +2 more
openaire   +4 more sources

Granulocyte-Macrophage Colony-Stimulating Factor in Psoriasis

Dermatology, 1990
Granulocyte-macrophage colony-stimulating factor (GM-CSF), a product of activated T lymphocytes, macrophages, endothelial cells, fibroblasts, and keratinocytes, is thought to play an important role in inflammatory reactions by ‘priming’ or enhancing the functions of neutrophils and macrophages.
H. Takematsu, Hachiro Tagami
openaire   +3 more sources